Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from General Services Administration was posted on December 17, 2019. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Research and Development Biomedical Solutions Provider

Closed
ID0720BMRDFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Grant
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-012
The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 3 months
NAICS: 541714
New
Grant
Immune Tolerance Network (UM1 Clinical Trial Required)
Solicitation # RFA-AI-28-005
The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 3 months
NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 25 days
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price request for a Blanket Purchase Agreement (BPA) to provide next generation amplicon sequencing services for the USGS Upper Midwest Water Science Center’s Michigan Bacteriological Research Laboratory. The scope of work includes providing all equipment, labor, travel, and materials necessary to support research on bacterial pathogens, harmful algal blooms, microbial ecology, antibiotic resistance, and microbial source tracking. Key technical requirements include the use of Illumina MiSeq or AVITI sequencing technologies and the potential for library preparation for 16S V4 amplicon sequencing. The BPA has a total not-to-exceed value of 250,000 dollars with an estimated period of performance from September 17, 2026, to September 16, 2031. The award process prioritizes non-priced factors significantly over cost, focusing on the offeror's qualifications and technical performance. Evaluation criteria include a detailed listing of on-site equipment and calibration dates, personnel experience, internal quality assurance procedures, and a technical narrative not exceeding two pages. Performance will be executed in Lansing, Michigan, with delivery terms set as FOB Destination. Administrative requirements include electronic invoicing via the Internet Payment Platform and compliance with various federal regulations, including the Buy American Act and specific security prohibitions regarding telecommunications equipment. Proposals must be submitted to the USGS OAG Denver Acquisition Branch by September 11, 2026.
Ofc Of Acquisition Grants-Denver

POSTED

5 days ago

DEADLINE

in 2 days

General Info

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

TX, USA

Set-Aside

NONE

Documents

1

59th Medical Wing Technical Clinical Research Team (TCRT) Draft Scope

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

Sources Sought

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGeneral Services Administration → Its/ Netwrk Svcs Contract Opns DIV1
Contacts1 person available
OfficeWASHINGTON, DC, 20405, USA
Office AddressWASHINGTON, DC, 20405, USA
Contacts
David Kilbourne

Full Description

Show more
General Services Administration Federal Acquisition Service Region 7 AAS SOURCES SOUGHT NOTICE (SSN)/ REQUEST FOR INFORMATION (RFI) SSN/RFI Number: ID0720BMRD Title: Research and Development Biomedical Solutions Provider 1. Market Research Notice This SSN/RFI is for planning and information purposes only and shall not be construed as a commitment or a promise of a contract by the Government. This is not a solicitation. This notice does not constitute an Invitation for Bid (IFB), Request for Quote (RFQ) or Request for Proposal (RFP), nor does it restrict the Government as to the ultimate acquisition approach. The Government will not reimburse respondents for any costs incurred in preparation of a response to this notice. For the purpose of this acquisition, the Government anticipates the use of one of the NAICS codes listed within this document and contemplates the use of single award Cost Reimbursement type contract. Information received in response to this notice will be used to further define the Government's requirement. We encourage all interested, large and small businesses in all socio-economic categories (including 8(a) Business Development Program, Small Disadvantaged Business, Historically under-utilized Business (HUB) Zone, Veteran-Owned Business, Service Disabled Veteran-Owned Business, and Woman-Owned Business concerns) capable of satisfying any portion of the listed requirement to identify their capabilities and provide their feedback. Information received as a result of this RFI will be used solely for market research purposes. The Government shall use this market research in determining the best method of procurement, which is part of the acquisition planning process. This RFI is for information purposes only and no award will result from the RFI. 2. Background and Anticipated Scope Background. The anticipated scope of this requirement has not been finalized and is subject to change. This is Phase one of a multi-phased market research approach to better understand the industry, capabilities, and factors impacting this anticipated requirement. Subsequent phases of this market research approach include teleconferences, comment on a draft PWS, and exchanges with industry. Anticipated Scope. The Government has a need for contract services to conduct translational research and development in the areas of emergency medical care, combat casualty care, force health protection, restorative medicine, clinical and rehabilitative medicine all with multiple centers of excellence (i.e., diabetes, eye, hearing, advanced molecular detection), and specialty centers (i.e., burn management and transport, cardio-vascular, extracorporeal life support and critical care transport, maternal and neonatal intensive care, pain management). This program continues to facilitate development of innovations for advancing the care and rehabilitation of the combat wounded and support for Food and Drug Administration (FDA) regulated trials supporting activities Enterprise-Wide. The potential awardee will need to be prepared to provide staffing for multiple labor categories and be able to provide highly technical research support and research solutions. Additionally, the potential awardee will need to be develop multiple approaches to potentially develop a cost effective solution for various research projects. Anticipated NAICS codes. 541714: Research and Development in biotechnology 541990: All Other Professional Scientific and Technical Services 3. Submission Requirements for RFI RESPONSE TO THIS RFI: In order to be considered responsive to this RFI, please provide a concise response to the items and questions posed in sections 4 - 6 along with any kind of capabilities brief you feel would help to inform the Government regarding your firm's experience, capabilities, or strategic sourcing partners. This RFI shall be open from December 17, 2019 through January 7th, 2020. Both large and small businesses are encouraged to participate in this phase of Market Research. A draft copy of the scope of work has been provided for reference. All responses are due not later than 10:00 PM Eastern, January 7th, 2020. All responses shall be submitted via email correspondence. Please send responses to david.kilbourne@gsa.gov 4. Firm Name and Admin Data a) Please provide Name of the firm, point of contact, phone number, email address, DUNS number, CAGE code, a statement regarding small business status, if applicable, (including small business type(s)/certifications(s) such as SDB, 8(a), HUBZone, SDVOSB, WOSB, etc.) and the corresponding NAICS codes. b) Please indicate if your firm would be interested in participating in an industry wide group teleconference call led by GSA Federal Acquisition Services (FAS) Region 7 (R7). If you would be interested in participating in this event, respond and provide point of contact information so the Government may contact your firm. Event dates and times to be determined after this SSN/RFI closes. 5. Previous Experience / Capabilities Statement a) Please provide a short statement addressing previous experience for similar requirements. Statement should address the following: Identify if you were a prime contractor or subcontractor, size, scope, complexity, and timeframe, whether the services provided were commercial or non-commercial, experience of conducting research and development in a biomedical setting, and any other similar types of information. The narrative shall draw direct correlations and relate directly to the requirement described herein, and shall directly demonstrate the interested contractor's capabilities to perform the effort herein through the examples of past experience provided. Failure to provide the information as requested may result in the Government's continuance of the acquisition planning phase, without giving consideration to the capabilities of the contractors who do not respond timely. 6. Questions Regarding Industry Specific Market Trends and Conditions. Special Notice: All information provided in response to this notice will be kept confidential and will be used for internal Governmental purposes only to help inform how we develop and solicit our anticipated requirement. a) Have you ever been the Prime for a Cost Reimbursement contract with the Government? b) What strategies or methods should the Government use to help control costs for this type of requirement? c) When working on a Research and Development project how do you determine the correct labor mix? d) Is it common for private firms and companies to partner with universities and research institutions in the biomedical R&D field? e) Are you able to partner with universities or research institutions to obtain skilled expertise and labor at a reduced rate? f) What controls or countermeasures does your company have in place to control costs and mitigate cost overrun on your projects? g) What criteria do you look for when you determine whether or not you will submit a proposal? h) How long does it take you to find and onboard new employees from the time you receive notification that you need a new employee, until they start the job? i) Do you have an approved accounting system to qualify for a Government Cost Reimbursement type contract? j) How many employees does your company currently employ? k) What unique characteristics should the Government look for in a contractor to be successful in the R&D biomedical industry? l) What potential hazards or concerns should the Government be aware of when hiring a contractor in the R&D biomedical industry? m) How is profit structured or determined for a private firm in the biomedical R&D industry? n) Is there a labor shortage in the biomedical R&D industry? o) What private firms should the Government be aware of that are leading the biomedical R&D field? p) Do highly skilled personnel in this field frequently change employment with companies in order to seek higher pay raises? q) What does your company do to create stability with your staffing and help retain highly skilled employees? r) Do highly skilled personnel in this field prefer long term employment or do they prefer to have short term employment? s) Do the employees you hire prefer part time or full time employment? t) How do you gain access to new employees with specialized skillsets? u) What credentials and certifications do you feel a successful and competent private firm would need to perform on a Government Biomedical R&D contract? v) Has your company ever performed work to gain approval from the Federal Drug Administration (FDA) for a drug, product, or medical device? w) Please provide any experience your company has with obtaining approval from the FDA for a drug, product, or medical device. x) Please identify any current Industry trends taking place that the Government would need to understand or be aware of for this requirement. Thank you in advance for your time and consideration in responding to this Sources Sought Notice / Request for Information.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS